Literature DB >> 1776888

Enhanced thrombin generation in patients receiving intensive care.

G Balakrishnan1, J Brownlie, R Webber, B Gibson.   

Abstract

Thrombin-antithrombin III complex (TAT) concentration was measured in 27 control and 155 intensive care patients to (a) establish normal reference ranges, (b) measure thrombin generation in critically ill patients, and (c) determine the characteristics of the TAT assay for the diagnosis of disseminated intravascular coagulation (DIC) in children. The normal reference range was 1-4.3 micrograms/l (median 2.3 micrograms/l), and 89.7% of patients had raised TAT concentrations. Median TAT concentrations in the presence of DIC (27 micrograms/l) were significantly higher than in its absence (8 micrograms/l). Sensitivity, specificity, and positive and negative predictive values of the assay were 97.3%, 28.3%, 76.3%, and 81.3%, respectively, at a cut off of 4 micrograms/l. Excess thrombin production occurs in the majority of critically ill children. The TAT assay is potentially useful in the diagnosis of DIC in children.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1776888      PMCID: PMC1793379          DOI: 10.1136/adc.66.12.1413

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay.

Authors:  H Pelzer; A Schwarz; N Heimburger
Journal:  Thromb Haemost       Date:  1988-02-25       Impact factor: 5.249

2.  Immunological determination of proteinase inhibitor complexes (PICs) and their behaviour during plasma derivate treatment in septic infections.

Authors:  R Egbring; R Seitz; H Blanke; T Menges; R Südhoff; T Stober; G Kolb; L Lerch
Journal:  Prog Clin Biol Res       Date:  1989

3.  The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.

Authors:  R Egbring; R Seitz; H Blanke; J Leititis; H J Kesper; R Burghard; G Fuchs; L Lerch
Journal:  Behring Inst Mitt       Date:  1986-02

4.  The disturbance of hemostasis in septic shock: role of neutrophil elastase and thrombin, effects of antithrombin III and plasma substitution.

Authors:  R Seitz; M Wolf; R Egbring; K Havemann
Journal:  Eur J Haematol       Date:  1989-07       Impact factor: 2.997

5.  Laboratory diagnosis of pulmonary embolism: value of increased levels of plasma D-dimer and thrombin--antithrombin III complexes.

Authors:  H Bounameaux; D Slosman; P de Moerloose; G Reber
Journal:  Biomed Pharmacother       Date:  1989       Impact factor: 6.529

6.  Thrombin-antithrombin III complexes for the detection of postoperative hypercoagulable state in surgical patients receiving heparin prophylaxis.

Authors:  J Bogaty-Yver; M Samama
Journal:  Thromb Haemost       Date:  1989-06-30       Impact factor: 5.249

7.  Anticoagulant action of heparin.

Authors:  P S Damus; M Hicks; R D Rosenberg
Journal:  Nature       Date:  1973-12-07       Impact factor: 49.962

8.  Clotting activation and impairment of fibrinolysis in malignancy.

Authors:  E Rocha; J A Páramo; F J Fernández; B Cuesta; M Hernández; M J Paloma; J Rifón
Journal:  Thromb Res       Date:  1989-06-15       Impact factor: 3.944

9.  Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma.

Authors:  J A Hoek; A Sturk; J W ten Cate; R J Lamping; F Berends; J J Borm
Journal:  Clin Chem       Date:  1988-10       Impact factor: 8.327

10.  Diagnosis of disseminated intravascular coagulation. Role of D-dimer.

Authors:  J M Carr; M McKinney; J McDonagh
Journal:  Am J Clin Pathol       Date:  1989-03       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.